Bill > S889

This bill, known as the Prescription Drug Monitoring Act of 2021, requires covered states (those receiving funding from federal prescription drug monitoring programs) to implement certain provisions related to prescription drug monitoring programs (PDMPs). Specifically, the bill mandates that covered states require prescribing practitioners to consult their state's PDMP before initiating treatment with certain controlled substances, and then every 3 months thereafter. It also requires PDMPs to provide proactive notifications to practitioners when patterns indicative of controlled substance misuse are detected. Additionally, the bill requires dispensers to report controlled substance prescriptions to the PDMP within 24 hours and for the PDMP data to be made available for public and private use, including by healthcare providers, health plans, and researchers. If a covered state fails to comply with these requirements, the Attorney General or the Secretary of Health and Human Services may withhold grant funds from the state.

Health and Social Services

https://www.congress.gov/bill/117th-congress/senate-bill/889/all-info